

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Genetics and epigenetics of pediatric leukemia in... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1104/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1104" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Genetics and epigenetics of pediatric leukemia in the era of precision medicine" />
    
            <meta name="og:title" content="F1000Research Article: Genetics and epigenetics of pediatric leukemia in the era of precision medicine.">
            <meta name="og:description" content="Read the latest article version by Kristie N Ramos, Irma N Ramos, Yi Zeng, Kenneth S Ramos, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15926">
            <meta name="article-id" content="14634">
            <meta name="dc.title" content="Genetics and epigenetics of pediatric leukemia in the era of precision medicine">
            <meta name="dc.description" content="Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here.">
            <meta name="dc.subject" content=" Epigenetics, Precision Medicine, Pediatric Leukemia">
            <meta name="dc.creator" content="Ramos, Kristie N">
            <meta name="dc.creator" content="Ramos, Irma N">
            <meta name="dc.creator" content="Zeng, Yi">
            <meta name="dc.creator" content="Ramos, Kenneth S">
            <meta name="dc.date" content="2018/07/18">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14634.1">
            <meta name="dc.source" content="F1000Research 2018 7:1104">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content=" Epigenetics">
            <meta name="prism.keyword" content="Precision Medicine">
            <meta name="prism.keyword" content="Pediatric Leukemia">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/07/18">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1104">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14634.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1104">
            <meta name="citation_title" content="Genetics and epigenetics of pediatric leukemia in the era of precision medicine">
            <meta name="citation_abstract" content="Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here.">
            <meta name="citation_description" content="Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here.">
            <meta name="citation_keywords" content=" Epigenetics, Precision Medicine, Pediatric Leukemia">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Kristie N Ramos">
            <meta name="citation_author_institution" content="Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona College of Medicine-Tucson, Tucson, USA">
            <meta name="citation_author" content="Irma N Ramos">
            <meta name="citation_author_institution" content="Department of Promotion Health Sciences, University of Arizona Mel and Enid Zucherman College of Public Health, Tucson, USA">
            <meta name="citation_author" content="Yi Zeng">
            <meta name="citation_author_institution" content="Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Arizona College of Medicine-Tucson, Tucson, USA">
            <meta name="citation_author_institution" content="University of Arizona Cancer Center, Tucson, USA">
            <meta name="citation_author" content="Kenneth S Ramos">
            <meta name="citation_author_institution" content="Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona College of Medicine-Tucson, Tucson, USA">
            <meta name="citation_author_institution" content="University of Arizona Cancer Center, Tucson, USA">
            <meta name="citation_author_institution" content="Department of Medicine, Division of Clinical Support and Data Analytics, University of Arizona College of Medicine-Phoenix, Phoenix, USA">
            <meta name="citation_publication_date" content="2018/07/18">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1104">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14634.1">
            <meta name="citation_firstpage" content="1104">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1104/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1104.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15926 /> <input type=hidden id=articleId name=articleId value=14634 /> <input type=hidden id=xmlUrl value="/articles/7-1104/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1104-v1.xml"> <input type=hidden id=article_uuid value=0fe6f3da-4f45-424f-8298-0785c40d9769 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Genetics and epigenetics of pediatric leukemia in the era of precision medicine"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14634.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14634.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1104"
  },
  "headline": "Genetics and epigenetics of pediatric leukemia in the era of precision medicine",
  "datePublished": "2018-07-18T14:22:04",
  "dateModified": "2018-07-18T14:22:04",
  "author": [
    {
      "@type": "Person",
      "name": "Kristie N Ramos"
    },    {
      "@type": "Person",
      "name": "Irma N Ramos"
    },    {
      "@type": "Person",
      "name": "Yi Zeng"
    },    {
      "@type": "Person",
      "name": "Kenneth S Ramos"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1104/v1",
            "name": "Genetics and epigenetics of pediatric leukemia in the era of precision..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Genetics and epigenetics of pediatric leukemia in the era of precision... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15926 data-id=14634 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14634.1" data-recommended="" data-doi="10.12688/f1000research.14634.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1104/v1/pdf?article_uuid=0fe6f3da-4f45-424f-8298-0785c40d9769" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14634-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14634-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14634-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Ramos KN, Ramos IN, Zeng Y and Ramos KS. Genetics and epigenetics of pediatric leukemia in the era of precision medicine [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1104 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14634.1" target=_blank>https://doi.org/10.12688/f1000research.14634.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14634-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14634 id=track-article-signin-14634 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14634?target=/articles/7-1104/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15926 /> <input name=articleId type=hidden value=14634 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Genetics and epigenetics of pediatric leukemia in the era of precision medicine</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Kristie N Ramos<sup>1</sup>,&nbsp;</span><span class="">Irma N Ramos<sup>2</sup>,&nbsp;</span><span class="">Yi Zeng<sup>3,4</sup>,&nbsp;</span><span class=""><a href="mailto:ksramos@email.arizona.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Kenneth S Ramos</span></a><a href="https://orcid.org/0000-0002-0692-4066" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0692-4066</div><sup>1,4,5</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Kristie N Ramos<sup>1</sup>,&nbsp;</span><span class="">Irma N Ramos<sup>2</sup>,&nbsp;</span><span class="">Yi Zeng<sup>3,4</sup>,&nbsp;</span><span class=""><a href="mailto:ksramos@email.arizona.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Kenneth S Ramos</span></a><a href="http://orcid.org/0000-0002-0692-4066" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0692-4066</div><sup>1,4,5</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 18 Jul 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14634.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona College of Medicine-Tucson, Tucson, USA<br/> <sup>2</sup> Department of Promotion Health Sciences, University of Arizona Mel and Enid Zucherman College of Public Health, Tucson, USA<br/> <sup>3</sup> Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Arizona College of Medicine-Tucson, Tucson, USA<br/> <sup>4</sup> University of Arizona Cancer Center, Tucson, USA<br/> <sup>5</sup> Department of Medicine, Division of Clinical Support and Data Analytics, University of Arizona College of Medicine-Phoenix, Phoenix, USA<br/> <p> <div class=margin-bottom> Kristie N Ramos <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Irma N Ramos <br/> <span>Roles: </span> Data Curation, Formal Analysis, Funding Acquisition, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Yi Zeng <br/> <span>Roles: </span> Formal Analysis, Funding Acquisition, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Kenneth S Ramos <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36469-35952></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36470-35953></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Epigenetics, Precision Medicine, Pediatric Leukemia </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Kenneth S Ramos (<a href="mailto:ksramos@email.arizona.edu">ksramos@email.arizona.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Kenneth S Ramos </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported in part by funds from the University of Arizona Health Sciences program in precision medicine. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Ramos KN <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Ramos KN, Ramos IN, Zeng Y and Ramos KS. Genetics and epigenetics of pediatric leukemia in the era of precision medicine [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1104 (<a href="https://doi.org/10.12688/f1000research.14634.1" target=_blank>https://doi.org/10.12688/f1000research.14634.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 18 Jul 2018, <b>7</b>(F1000 Faculty Rev):1104 (<a href="https://doi.org/10.12688/f1000research.14634.1" target=_blank>https://doi.org/10.12688/f1000research.14634.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 18 Jul 2018, <b>7</b>(F1000 Faculty Rev):1104 (<a href="https://doi.org/10.12688/f1000research.14634.1" target=_blank>https://doi.org/10.12688/f1000research.14634.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e229>Impact statement</h2><p class="" id=d10215e232>Despite major advances in the treatment of pediatric leukemias, the etiology of pediatric leukemia remains largely unknown. Recent advances in molecular genetics and genomic medicine are discussed here that exemplify progress in the molecular classification of this group of diseases, the genetic and epigenetic strategies to risk-stratify patients, and the optimization of precision therapies to target initiator lesions and biochemical pathways involved in leukemogenesis. Although significant advances have been made, much work remains to be done to fully realize the power of precision approaches and therapeutics in the treatment of pediatric leukemias.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e238>Pediatric leukemias</h2><p class="" id=d10215e241>Pediatric leukemias result from germline and somatic mutations that act in concert with disturbances of the epigenetic machinery to give rise to altered phenotypes. Despite the large variety of mutations characterized to date and evidence pointing to the involvement of immune system defects in the context of environmental exposures<sup><a href="#ref-1">1</a></sup>, the exact etiology of pediatric leukemia remains largely unknown. Advances in molecular genetics and genomic medicine now allow a more precise and comprehensive classification of this group of diseases, finer resolution of genetic and epigenetic strategies to risk-stratify patients, and optimization of precision therapies to target the initiator lesions and biochemical pathways involved in leukemogenesis. Given that acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy<sup><a href="#ref-2">2</a></sup>, this review will focus on ALL unless otherwise noted.</p><p class="" id=d10215e252>Genomic profiling of ALL samples has identified a constellation of structural rearrangements, submicroscopic DNA copy number alterations, and sequence mutations<sup><a href="#ref-3">3</a></sup>, and a large degree of heterogeneity in molecular deficits is associated with ALL at diagnosis and relapse. For example, the acquisition of additional high-risk genetic mutations across all genetic subtypes in relapsed ALL clearly differentiates genetic profiles relative to time of original diagnosis<sup><a href="#ref-4">4</a></sup>. Nearly 20% of relapsed ALL specimens contain mutations in CREB-binding protein (CREBBP), a genetic deficit associated with changes in histone acetylation/deacetylation<sup><a href="#ref-5">5</a></sup>, and cases of relapsed ALL have also been associated with mutations in KRAS, 5′-nucleotidase, cytosolic II (NT5C2), phoshoribosyl pyrophosphate synthetase 1 (PRPS1), NRAS, fms-related tyrosine kinase 3 (FLT3) receptor, and PTPN11<sup><a href="#ref-6">6</a>–<a href="#ref-9">9</a></sup>. This genomic heterogeneity emphasizes the importance of genetic and epigenetic interactions as key determinants of clinical presentation and progression of ALL phenotypes.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e277>Genetic and epigenetic mechanisms of leukemogenesis</h2><p class="" id=d10215e280>Chromosomal rearrangements create fusion gene products, and the expression of these gene products in combination with age, white blood cell count, the presence or absence of central nervous system or testicular disease (or both) at time of diagnosis, and minimal residual disease status is the basis for prognosis prediction and disease management<sup><a href="#ref-5">5</a></sup>. Sentinel chromosomal translocations occur in nearly all cases of childhood B-cell ALL and many of these represent initiating events of prognostic significance; however, a major diagnostic challenge is that some of these genetic changes are not readily detectable by cytogenetic analysis of metaphase chromosomes and require reverse transcription–polymerase chain reaction (RT-PCR) amplification or fluorescence <i>in situ</i> hybridization (FISH) for accurate detection<sup><a href="#ref-10">10</a></sup>. In some instances, BCR-ABL mutations, IKZF1 (also known as Ikaros) deletions, fusions of tyrosine kinase or CRLF1, and mutations of JAK1 and JAK2 are being tested in clinical trial settings. The availability of next-generation sequencing-based gene panels to evaluate pediatric cancers in the future may help to advance current standards of clinical practice (<a target=xrefwindow href="https://www.businesswire.com/news/home/20160218006343/en/Children" id=d10215e293>https://www.businesswire.com/news/home/20160218006343/en/Children</a>).</p><p class="" id=d10215e297>ETV6-RUNX1 rearrangements are of particular interest given their involvement in 25% of standard-risk childhood B-cell ALL<sup><a href="#ref-10">10</a></sup>. Interestingly, ETV6-RUNX1 mutations can be detected in samples from patients who do not go on to develop ALL, suggesting that this translocation functions in the context of additional mutations to become pathogenic<sup><a href="#ref-11">11</a></sup>. Rearrangements of KMT2A (also known as mixed lineage leukemia 1, or MLL1) are also of interest given that over 100 fusion partners have been identified which combine sequence alterations with loss of epigenetic control through disruption of lysine methyltransferase activity<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. KMT2A rearrangements occur in about 75% of infants with B-cell ALL, especially those less than six months of age, and in 2% of older children, adolescents, and adults with ALL<sup><a href="#ref-13">13</a></sup>. Additionally, FLT3 is commonly overexpressed in infant patients with KMT2A rearrangements<sup><a href="#ref-14">14</a></sup>, but the use of FLT3 inhibitors has not resulted in advantageous clinical outcomes<sup><a href="#ref-15">15</a></sup>. Thus, current efforts are focused on drug candidates targeting histone deacetylases (HDACs) or methyltransferases as possible therapeutic agents (ClinicalTrials.gov Identifiers: NCT02141828, NCT01483690, NCT01321346, and NCT02828358)<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d10215e332>The BCR-ABL1 rearrangement resulting from the t(9;22)(q34;q11.2) fusion (that is, Philadelphia chromosome) is present in nearly all chronic myelocytic leukemia cases as well as a subset of patients with ALL (3 to 5% of childhood B-cell ALL)<sup><a href="#ref-10">10</a></sup>. Ph<sup>+</sup> ALL cases oftentimes carry deletions in IKZF1 and PAX5 (also known as paired box 5) transcription factors, both of which are involved in the regulation of B-cell development<sup><a href="#ref-16">16</a></sup>. Studies to evaluate the efficacy of imatinib—an ABL tyrosine kinase inhibitor (TKI)—in combination with intensive chemotherapy in children with Ph<sup>+</sup> ALL have reported dramatic improvements in overall survival<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>. However, because long-term imatinib therapy can result in ABL tyrosine kinase domain point mutations that afford decreased TKI sensitivity, additional research into effective combination therapies that can specifically target molecular deficits is needed<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>.</p><p class="" id=d10215e364>A BCR-ABL1–like ALL has also been described with activated kinase expression profiles that closely resemble Ph<sup>+</sup> ALL but that also involve unregulated activation of cytokine signaling pathways and mutation of B cell–associated transcription factors<sup><a href="#ref-16">16</a>,<a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. Translocation of “Abelson kinase (ABL) class” genes such as ABL1, ABL2, colony-stimulating factor 1 receptor (CSF1R), and platelet-derived growth factor receptor beta (PDGFRB) results in fusion proteins that activate receptor tyrosine kinase or non-receptor tyrosine kinase signaling<sup><a href="#ref-23">23</a></sup>. A very high frequency of <i>IKZF1</i> deletions, fusions of tyrosine kinase genes, fusions of <i>CRLF2</i>, and mutations of <i>JAK1</i> and <i>JAK2</i> have been detected in patients with Ph-like ALL<sup><a href="#ref-16">16</a>,<a href="#ref-23">23</a></sup>. High-risk B-ALL patients who are Ph-like have a predicted five-year event-free survival of less than 60%<sup><a href="#ref-24">24</a></sup>. Since tyrosine kinase fusion partners, including <i>ABL1</i>, <i>ABL2</i>, <i>CSF1R</i>, <i>PDGFRB</i>, and <i>FGFR</i>, respond well to the addition of TKIs<sup><a href="#ref-23">23</a></sup>, introducing TKI therapy after induction chemotherapy may improve survival in patients with Ph-like ALL. The safety and efficacy of dasatinib in combination with standard conventional chemotherapy in treating Ph-like ALL in children are currently being tested in a Children’s Oncology Group clinical trial (ClinicalTrials.gov Identifier: NCT02883049).</p><p class="" id=d10215e429>Although genetic and epigenetic profiling data on T-cell ALL are not as abundant as what has been published on B-cell ALL, Furness <i>et al</i>. recently demonstrated interesting findings in regard to the evolution of genetic alterations in STIL-TAL1 + T-cell ALL<sup><a href="#ref-25">25</a></sup>. Using single-cell multicolor FISH, Furness <i>et al</i>. found that both STIL-TAL1 fusion and loss of both CDKN2A alleles were present in the earliest detectable leukemic subclones but that other alterations such as NOTCH1 and PTEN mutations appeared to be secondary events. These findings are of significance given that (1) these mutational events can serve as potential markers for minimal residual disease monitoring and (2) the TAL1 regulatory complex could be a future target for therapy<sup><a href="#ref-25">25</a></sup>. Further studies are needed to examine the genetic and epigenetic complexity that exists among T-cell ALL subtypes.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e449>Molecular mechanisms of epigenetic control in leukemogenesis</h2><p class="" id=d10215e452>Many of the chromosomal rearrangements that alter cellular differentiation and result in leukemogenesis do so by interfering with epigenetic mechanisms or the epigenetic machinery or both<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. As such, a brief discussion of the molecular deficits in epigenetic control within the context of leukemogenesis is warranted. Epigenetic mechanisms encompass a repertoire of heritable alterations in gene expression that occur in the absence of changes to the DNA sequence. In the case of leukemias, epigenetics carries added significance given that B- and T-cell maturation is associated with changes in DNA structure that allow these cells to differentially recognize molecules and that, by necessity, will require further fine-tuning through the epigenetic machinery. Transient changes in the epigenetic machinery, as seen upon binding of transcription factors to DNA or the reversible acetylation of histones to mediate chromatin unwinding, are not heritable. Instead, epigenetics is concerned mainly with covalent DNA and histone modifications that are replicated in daughter cells upon cell division. The placement, removal, and interpretation of these marks are denoted in the literature as writers, erasers, and readers, respectively, to identify the complex set of enzymes that catalyze these reactions.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e465>DNA methylation</h2><p class="" id=d10215e468>DNA methylation is a pivotal component of cellular differentiation, gene expression, and genome-wide maintenance and stability and is currently recognized as the most prevalent epigenetic modification in the development of ALL. Methylation within the 5′–3′ cytosine guanine (CpG) dinucleotide sequence has been most studied, particularly in regions of the genome having a GC content greater than 50% and thus referred to as CpG islands<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. These islands are generally found in the 5′ region of genes and are specifically involved in regulation of gene expression. DNA methyltransferases (DNMTs) (1, 2, 3a, and 3b) are the enzymes responsible for the transfer of methyl groups and are known to play important roles in the development and progression of cell division.</p><p class="" id=d10215e478>Both targeted and genome-wide alterations in DNA methylation can play key etiological roles in pediatric leukemias<sup><a href="#ref-28">28</a>,<a href="#ref-30">30</a></sup>. Initial studies have suggested that aberrant promotor methylation is associated with prognosis<sup><a href="#ref-31">31</a></sup>, cytogenetic alterations<sup><a href="#ref-32">32</a></sup> and subtypes<sup><a href="#ref-33">33</a></sup>, and likelihood of relapse<sup><a href="#ref-34">34</a></sup>. Subsequent studies have identified hypermethylated CpG islands across various genetic and immunophenotypic leukemia subtypes, suggesting that deficits in DNA methylation are key to malignant transformation across multiple ALL subtypes<sup><a href="#ref-34">34</a>–<a href="#ref-38">38</a></sup>. Others have presented data suggesting that bidirectional allele-specific gene expression may be due to random distribution of CpG methylation<sup><a href="#ref-39">39</a></sup>. A caveat of these studies is the small number of patients examined, thus limiting the clinical generalizability of these findings.</p><p class="" id=d10215e516>Analysis of 137 B-cell lineage and 30 T-cell lineage childhood ALL samples using microarrays and genome-wide cytosine methylation profiling has shown that different ALL subtypes exhibit unique DNA methylation signatures that correlate with gene expression patterns<sup><a href="#ref-39">39</a></sup>. Importantly, a common epigenetic methylation signature involving signaling molecules (TIE1, MOS, CAMLG, and GPRC5C), cell cycle regulation and proliferation (MCTS1 and DGKG), RNA metabolism (PABPN1 and PABPC5), transcription factors and transcription regulators (PROP1, TAF3, H2AFY2, ELF5, ZBTB16, CNOT1, and TADA2A), and homeobox genes (HOXA5 and HOXA6) was identified in all cases of ALL examined<sup><a href="#ref-39">39</a></sup>. This analysis compared all leukemia samples against a cohort of normal B cells at various stages of differentiation, confirming that the methylation signature could not be attributed to differentiation status alone. The common epigenetic signature correlated with gene expression in 65% of the genes identified, supporting the conclusion that alterations in cytosine methylation likely impact leukemogenesis.</p><p class="" id=d10215e527>Although survival is relatively high for patients with ALL managed in accordance with established protocols, the prognosis for relapsed patients remains a major clinical challenge<sup><a href="#ref-40">40</a></sup>. Thus, efforts to identify biomarkers of relapse at the time of diagnosis can be of great clinical benefit and help guide future treatment modalities. In this regard, numerous studies have attempted to use DNA methylation signatures at diagnosis to predict relapse<sup><a href="#ref-36">36</a>,<a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup> but these studies have yielded variable results in small patient cohorts. In a study of 33 B-cell precursor ALL cases by Hogan <i>et al</i>., higher DNA methylation levels in CpG islands were measured at relapse<sup><a href="#ref-44">44</a></sup>. In another study, by Nordlund <i>et al</i>., 27 paired samples with variable ALL subtypes showed that relapse-associated CpG sites overlapped with genes regulated by transcription factors such as REST, SOX2, NANOG, and OCT4<sup><a href="#ref-36">36</a></sup>. Conversely, a study by Kunz <i>et al</i>. examined 13 T-cell ALL paired samples and reported increased hypomethylation of promotor regions in relapsed samples<sup><a href="#ref-45">45</a></sup>. Such heterogeneity of findings likely reflects epigenetic and genomic alterations throughout disease progression and across different leukemia subtypes.</p><p class="" id=d10215e567>To date, alterations in DNA methylation have generally been studied in solid malignancies, and increased DNA methylation and consequent silencing have been notable in promotor regions coupled with global hypomethylation of repetitive elements and subsequent genomic instability. In sharp contrast, Bujko <i>et al</i>.<sup><a href="#ref-46">46</a></sup> reported that repetitive elements tend to be hypermethylated in hematologic malignancies. These investigators examined overall DNA methylation status of LINE-1 and ALU elements in patients with adult acute myeloid leukemia (AML) and childhood B-cell lymphoblastic leukemia. Higher DNA methylation of LINE-1 was observed in adult AML and pediatric ALL samples compared with normal controls, and additional increased methylation of ALUs was observed in patients with B-cell ALL. Furthermore, higher methylation levels were seen in B-cell ALL samples compared with both AML and control samples, and a positive correlation was seen between DNA methylation and total leukocyte count<sup><a href="#ref-46">46</a></sup>. Although the significance of these findings remains to be established, the data suggest that regulatory control of repetitive sequences involved in chromosomal rearrangements is differentially regulated compared with other cancer types.</p><p class="" id=d10215e581>In the aforementioned study by Hogan <i>et al</i>., DNA methylation was examined in 33 matched B-cell precursor ALL samples at the time of diagnosis compared to relapse. A total of 1147 CpG sites in 905 genes showed increased methylation levels at relapse. More specifically, gene expression profiles also differed for early relapse (less than 36 months) versus late relapse (greater than or equal to 36 months). Many of the unique targets were genes within the Wnt signaling cascade<sup><a href="#ref-44">44</a></sup> and were subsequently found to be responsive to decitabine<sup><a href="#ref-47">47</a></sup>, potentially implicating the Wnt pathway in relapsed disease. These data speak to the role of epigenetic modifications in leukemic disease progression and again suggest the possible use of DNA methylation inhibitors as therapeutic agents.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e599>Covalent histone modifications</h2><p class="" id=d10215e602>Histone tail modifications (such as acetylation, methylation, phosphorylation, sumoylation, and ubiquitylation) can alter gene expression, and specific marks and positions within the N-terminal tail are linked to either transcriptional activation or repression<sup><a href="#ref-48">48</a></sup>. Histone modifications are catalyzed by various enzymes, including histone lysine demethylases (HKDMs), histone acetyltransferases (HATs), and HDACs, which in coordination with other DNA-binding proteins help to define chromatin architecture. Four core histone proteins (H2A, H2B, H3, and H4) form a basic scaffolding structure called a nucleosome, and post-translational modifications of histone tails go on to define chromatin architecture and control chromatin accessibility. Acetylation and methylation are stable modifications that regulate gene expression, and modifications such as these are subject to epigenetic control. Other modifications such as phosphorylation, sumoylation, and ubiquitylation represent transient modifications of functional significance. The combination of both stable and transient histone modifications is often referred to as the “histone code” that defines the terms of transcriptional regulation for the genome.</p><p class="" id=d10215e609>To date, a number of studies have implicated covalent histone modification in the development of pediatric ALL. For example, a t(4;11) translocation results in the creation of the KMT2A-AF4 fusion gene, which is the most common KMT2A rearrangement identified to date in infant ALL<sup><a href="#ref-40">40</a></sup>. This fusion protein binds fewer genomic regions than KMT2A wild-type, leading to abnormal DNA methylation and extensive chromatin remodeling<sup><a href="#ref-49">49</a></sup>. However, not all infant ALL samples contain KMT2A rearrangements and thus studies have sought to examine the genetic abnormalities in these cases. As such, a BRD9-NUTM1 fusion gene resulting from t(5;15)(p15;q14) was described in two KMT2A-r–negative infant ALL cases<sup><a href="#ref-12">12</a>,<a href="#ref-50">50</a></sup>. Additionally, BRD9 is a bromodomain-containing protein that likely functions in chromatin remodeling and that has recently been implicated in AML<sup><a href="#ref-51">51</a></sup>, while NUTM1 enhances the HAT activity of EP300, a CREBBP homolog known to fuse with BRD4 in NUT midline carcinoma<sup><a href="#ref-52">52</a></sup>. Furthermore, recent transcriptome sequencing studies have found other NUTM1 fusion genes in severe sporadic ALL cases (including IKZF1-NUTM1, AFF1-NUTM1, and ZNF618-NUTM1)<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. The development of innovative personalized therapies based on the use of DOT1L inhibitors for the treatment of pediatric and adult MLLr has shown encouraging results<sup><a href="#ref-55">55</a></sup>. DOT1L catalyzes the mono-, di-, and tri-methylation of H3K79 within the ordered core of H3 and is required to initiate tumorigenesis and maintain the malignant phenotype of MLLr<sup><a href="#ref-56">56</a></sup>. Thus, DOT1L inhibitors hold considerable promise in the clinical management of leukemia.</p><p class="" id=d10215e651>In other studies, loss-of-function mutations in the CREBBP gene located on chromosome 16 have been observed in 18% of relapsed ALL cases as well as early T-cell precursor ALL<sup><a href="#ref-57">57</a></sup>. Zinc finger protein 284 (ZNF384) rearrangements have recently been described in a new subtype of B-cell precursor ALL, in which up to 80% of patients have a mutation of translocation involving an epigenetic regulating gene<sup><a href="#ref-54">54</a>,<a href="#ref-58">58</a></sup>. Importantly, fusion of ZNF384 with either CREBBP or EP300 results in dominant-negative loss of histone lysine acetyltransferase activity and global reduction of histone acetylation and subsequently increases sensitivity to HDAC inhibitors <i>in vitro</i><sup><a href="#ref-53">53</a></sup>. This emerging pattern implicates coordinated regulation between chromosomal rearrangements and epigenetic dysregulation as pivotal events in leukemogenesis. This interpretation opens the door for development of significant advances in precision diagnosis and treatment for pediatric leukemia involving ETV6-CBX3, RUNX1-ASXL1, and NOL4L-ASXL1 fusions<sup><a href="#ref-49">49</a>,<a href="#ref-53">53</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e681>MicroRNA mechanisms</h2><p class="" id=d10215e684>Altered microRNA (miRNA) expression has the ability to effect several known regulatory pathways in ALL pathogenesis<sup><a href="#ref-59">59</a>–<a href="#ref-62">62</a></sup>. miRNAs are small non-coding RNA molecules that function in transcriptional and post-transcriptional regulation of gene expression via base pairing with complementary sequences. The interaction of miRNAs with their target mRNAs results in cleavage of the mRNA strand, destabilization through poly(A) shortening, or deficits in translation or a combination of these. Although most of what we now understand about miRNA biology defines intracellular events, evidence establishing an important role for miRNAs as extracellular, circulating signaling molecules is fast accumulating<sup><a href="#ref-63">63</a></sup>. Over 1000 known miRNAs have been identified in the human genome<sup><a href="#ref-64">64</a></sup>, and of the miRNAs implicated in ALL, miR-34, miR-128, miR-142, and miR-181 are overexpressed<sup><a href="#ref-59">59</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup> whereas miR-100 and miR-196b are underexpressed<sup><a href="#ref-61">61</a>,<a href="#ref-65">65</a></sup>.</p><p class="" id=d10215e719>A study by Schotte <i>et al</i>. comparing 397 miRNAs in 81 pediatric ALL cases against 17 normal CD34<sup>+</sup> stem cell controls reported unique miRNA signatures for various ALL subtypes and found miR-143 and miR-140 to be 70- to 140-fold lower in B-cell ALL samples versus control<sup><a href="#ref-67">67</a></sup>. These investigators also examined the impact of miRNA expression on chemotherapy responsiveness and found that decreased miR-454 expression was associated with L-asparaginase resistance but that increased expression of miR-99, miR-100, and miR-125b was associated with vincristine and daunorubicin resistance. Furthermore, eight miRNAs (miR-10a, -134, -214, -484, -572, -580, -624, and -627) were associated with longer event-free survival, leading the team to hypothesize that those associated with increased event-free survival likely had tumor suppressor functions exerted via apoptotic signaling (miR-10a), inhibition of proliferation (miR-10a and -214), and downregulation of SOX2 (miR-134)<sup><a href="#ref-67">67</a></sup>. These findings have opened the door for the design of precision diagnostics where patients are screened for the presence of these miRNAs at time of diagnosis to define an optimal chemotherapy regimen for their disease. Furthermore, in cases where miRNA expression is repressed by hypermethylation<sup><a href="#ref-65">65</a>,<a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>, a DNMT inhibitor regimen could be implemented to reverse epigenetic modifications and improve survival.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e749>Transposable elements and leukemias: unanswered questions</h2><p class="" id=d10215e752>Little is known about the role of transposable elements in leukemogenesis, and most efforts to date have focused strictly on AML. A previous report on ALL has implicated translocation junctions at the transcription factor 3 (TCF3)/E2A immunoglobulin enhancer-binding factors E12/E47 (E2A) locus clustered within, or in proximity to, transposable element sequences<sup><a href="#ref-68">68</a></sup>. Transposable elements make up 45% of the human genome<sup><a href="#ref-69">69</a></sup>. Given the important role of these elements in regulating the transcriptional activity of genes, there is interest in determining their putative role in leukemogenesis. LINEs, abundant retrotransposons in the human genome, are major sites of epigenetic control because of the high density of CpG islands contained within these sequences. These elements influence gene expression via several mechanisms; the most notable and probably best understood is their ability to induce insertion mutations into open reading frames or intronic regions following a full cycle of retrotransposition.</p><p class="" id=d10215e763>Early studies of the life cycle of L1 retroelements established a causal relationship between L1 insertion mutations and cancer<sup><a href="#ref-70">70</a></sup>. More recently, data on hypomethylation-mediated reactivation of LINEs have prompted investigations aimed at elucidating the role of LINEs in the regulation of chromatin dynamics and genome stability across the full spectrum of human development. At its most fundamental level, L1 mobilization can disrupt local genome architecture, induce DNA strand breaks, mediate alternative splicing, increase the frequency of recombination, and induce loss of transcriptional control of neighboring genes. Most L1 insertions are truncated at the 5′ end and carry insertions/deletions that render these newly inserted elements unable to retrotranspose<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d10215e774>Previous work has established that genetic ablation of RB proteins leads to reactivation of L1 retroelements<sup><a href="#ref-16">16</a>,<a href="#ref-70">70</a></sup>. pRB interacts with HDAC1, DNMT1, pRB-associated protein 48 (RbAp48), suppressor of variegation 3-9 homolog 1 (<i>Drosophila</i>) (Suv39H1), and suppressor of variegation 4-20 homolog 2 (<i>Drosophila</i>) (Suv420H2) to induce signatures of epigenetic silencing<sup><a href="#ref-16">16</a></sup>. Epigenetic reactivation of L1 by DNA-damaging agents involves proteasomal-mediated degradation of DNMT1 and loss of RB-mediated silencing<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. These findings are of potential relevance given previous reports implicating Rb-1 as a prognostic factor in pediatric ALL<sup><a href="#ref-74">74</a></sup>.</p><p class="" id=d10215e806>Rb-1 is normally expressed in hematopoietic cells and inactivated by point mutations with predominance for exons 20–24 in various cancers. In these studies, bone marrow from 26 pediatric patients with leukemia (18 ALL and eight AML) was studied. In ALL cases, two samples in exon 20 (11.11%), one in exon 21 (5.56%), and four in exon 22 (22.22%) had altered conformation. All but one of these cases were classified as high-risk leukemia patients who either relapsed or never achieved remission. In addition to having the ability to disrupt the architecture of the genome, LINEs regulate gene expression patterns in cells via epigenetic mechanisms. Thus, leukemia may involve derangements in LINE-1 expression that compromise genome integrity and function. This hypothesis has never been rigorously examined.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10215e812>Perspectives for the precision medicine era</h2><p class="" id=d10215e815>Molecular signatures defined on the basis of DNA methylation, covalent histone modifications, and miRNA expression profiles can help to better stratify disease phenotypes both at the time of diagnosis and during the course of disease progression. Furthermore, these molecular signatures can optimize medical therapies designed to target specific molecular deficits and minimize adverse reactions. These are the foundational underpinnings of precision medicine, and although significant advances have been realized in the clinical management of several solid and liquid tumor malignancies, more remains to be done in the diagnosis and treatment of pediatric leukemias. Future avenues of research include systematic mapping of epigenetic modifications on a genome-wide scale in primary ALL cells to assess the impact of somatic mutations on cellular programming and, consequently, cellular behavior. In this context, the Blueprint Consortium (which maps human blood cell epigenomes) has contributed genome-wide data on histone modification in primary ALL cells from 15 patients with B-cell precursor ALL<sup><a href="#ref-75">75</a></sup>. Use of these data can help establish a regulatory mechanism for hereditary risk of high hyperdiploidy ALL, a hypothesis put forth by the consortium to evaluate a risk allele within the enhancer element on chromosome 10p21.2 that disrupts RUNX3 binding, decreases ARID5B expression, and arrests normal lymphocyte development to initiate leukemogenesis<sup><a href="#ref-76">76</a></sup>.</p><p class="" id=d10215e826>Deregulated H3K9ac<sup><a href="#ref-77">77</a></sup>, global acetylation<sup><a href="#ref-78">78</a></sup>, and increased HDAC activity<sup><a href="#ref-79">79</a></sup> occur in ALL cells, and epigenetic modifications are more commonly observed in relapsed ALL cases verses those at the time of diagnosis. Although we do know that epigenetic alterations are likely implicated in the initiation, development, and relapse of pediatric ALL, most epigenetic trials to date have been completed in adults and thus major knowledge gaps persist in regard to how this information translates to pediatric ALL cases. To date, the analysis of DNA methylation has proven valuable in determining leukemic cell origin and cytogenetic features and can be developed as a biomarker of ALL in the future. The challenge remains to understand how these and other epigenetic alterations operate within the framework of gene fusions and other somatic mutations in ways that can be targeted for precision medicine intervention.</p><p class="" id=d10215e841>The constitutive activation of kinase signaling pathways in ALL suggests that the development of kinase inhibitors that target specific molecular deficits may be of value in the precision medicine space. PDGFRB rearrangements commonly occur in patients who fail to respond to induction chemotherapy (greater than or equal to 25% residual disease). As such, this mutation can be screened for in cases where conventional therapies are of diminished value. To this end, current clinical trials are examining the use of dasatinib or ruxolitinib in combination with chemotherapy for patients with ABL-class fusions or JAK signaling pathway alterations, respectively<sup><a href="#ref-80">80</a></sup>.</p><p class="" id=d10215e848>Whole genome testing could be considered during induction therapy in order to identify appropriate clinical trials for these patients. The utility of this approach can be exemplified in patients with trisomy 21–associated ALL. These patients carry a 10-fold higher risk of developing ALL (almost always of B-cell lineage) in addition to an increased risk of chemotherapy toxicity<sup><a href="#ref-81">81</a></sup>. As many as 50 to 60% of Down syndrome–associated ALL cases have CRLF2 rearrangements, most commonly characterized as a P2RY8-CRLF2 fusion due to deletion of the pseudoautosomal region of the sex chromosomes<sup><a href="#ref-82">82</a></sup>. Fifty percent of CRLF2-rearranged Down syndrome–associated ALL cases have concomitant JAK mutations (commonly a JAK2 R683G point mutation)<sup><a href="#ref-83">83</a></sup>, but JAK inhibitors have yet to be formally evaluated in clinical trials.</p><p class="" id=d10215e864>Activating mutations in RAS pathway genes have also been identified in several pediatric ALL subtypes, including high hyperdiploid and hypodiploid ALL, infant ALL, and certain cases of Ph-like ALL<sup><a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>. Genes implicated include GTPases, KRAS, NRASM, HRAS, protein tyrosine phosphatase non-receptor type 11 (PTPN11), casitas B-lineage lymphoma (CBL), and FLT3. Further research is needed to elucidate the causal relationships in the context of leukemogenesis that would be of significance given that these gene targets would be suitable for the application of precision therapy.</p><p class="" id=d10215e874>The importance of precision approaches in the clinical management of pediatric leukemias is emphasized by the high frequency of chemoresistance-associated mutations during the course of therapy and the potential role of predisposing genetic polymorphisms in determining disease onset, progression, and response to treatment. Continued translational and clinical research is needed to further define (1) the evolving genomic complexity of the disease and (2) the need for stratification of a highly heterogeneous group of diseases. At the core of precision approaches in cancer is the need for better resolution of molecular phenotypes and the identification of mechanism-based and mechanism-agnostic approaches to prognosis, diagnosis, and clinical management of the disease.</p><p class="" id=d10215e877>A significant limitation at present is the need for coordinated drug discovery and drug repurposing programs that can help identify small molecules and biological approaches to therapy. Another challenge is the fact that most studies to date focus on the use of single agents in poor-phenotype cohorts. As such, concerted efforts are needed to evaluate combination therapies in a systematic fashion and to better match treatment to molecular phenotypes across a highly heterogeneous group of patients, and longitudinal follow-up is necessary to evaluate disease-free survival and long-term risks associated with therapy. Although significant advances have been made in this space, much work remains to be done in pediatric oncology to fully realize the power of precision approaches and therapeutics.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d10215e1 class=n-a></a><h2 class=main-title id=d10488>Author contributions</h2><p class=metadata-entry><a name=d10215e154 class=n-a></a><p id=d10215e156> KNR contributed to conceptualization, data curation, formal analysis, methodology, and writing (original draft preparation and review and editing). INR contributed to data curation, formal analysis, funding acquisition, validation, and writing (review and editing). YZ contributed to formal analysis, funding acquisition, validation, and writing (review and editing). KSR contributed to conceptualization, formal analysis, funding acquisition, methodology, validation, and writing (original draft preparation and review and editing).</p></p></div><div class=back-section><a name=d10215e1 class=n-a></a><h2 class=main-title id=d10492>Competing interests</h2><p class=metadata-entry><a name=d10215e160 class=n-a></a><p id=d10215e161> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d10215e1 class=n-a></a><h2 class=main-title id=d10494>Grant information</h2><p>This work was supported in part by funds from the University of Arizona Health Sciences program in precision medicine.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d10215e884 class=n-a></a><h2 class=main-title id=d10215e886>Acknowledgments</h2><p class="" id=d10215e889>We would like to thank Marco Tavera-Garcia for his assistance with manuscript preparation and submission.</p></div><div class=back-section><a name=d10215e893 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d10796>References</h2><div class="section ref-list"><a name=d10215e893 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725537314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e900 class=n-a></a>Brisson GD, Alves LR, Pombo-de-Oliveira MS: Genetic susceptibility in childhood acute leukaemias: a systematic review. <i>Ecancermedicalscience.</i> 2015; <b>9</b>: 539. <a target=xrefwindow id=d10215e908 href="http://www.ncbi.nlm.nih.gov/pubmed/26045716">PubMed Abstract </a> | <a target=xrefwindow id=d10215e911 href="http://dx.doi.org/10.3332/ecancer.2015.539">Publisher Full Text </a> | <a target=xrefwindow id=d10215e914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4448992">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725537314">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d10215e927 class=n-a></a>Ward E, DeSantis C, Robbins A, <i> et al.</i>: Childhood and adolescent cancer statistics, 2014. <i>CA Cancer J Clin.</i> 2014; <b>64</b>(2): 83–103. <a target=xrefwindow id=d10215e938 href="http://www.ncbi.nlm.nih.gov/pubmed/24488779">PubMed Abstract </a> | <a target=xrefwindow id=d10215e941 href="http://dx.doi.org/10.3322/caac.21219">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9343957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e950 class=n-a></a>Mullighan CG, Zhang J, Kasper LH, <i> et al.</i>: CREBBP mutations in relapsed acute lymphoblastic leukaemia. <i>Nature.</i> 2011; <b>471</b>(7337): 235–9. <a target=xrefwindow id=d10215e961 href="http://www.ncbi.nlm.nih.gov/pubmed/21390130">PubMed Abstract </a> | <a target=xrefwindow id=d10215e964 href="http://dx.doi.org/10.1038/nature09727">Publisher Full Text </a> | <a target=xrefwindow id=d10215e968 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3076610">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9343957">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725877018"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e981 class=n-a></a>Hunger SP, Mullighan CG: Acute Lymphoblastic Leukemia in Children. <i>N Engl J Med.</i> 2015; <b>373</b>(16): 1541–52. <a target=xrefwindow id=d10215e989 href="http://www.ncbi.nlm.nih.gov/pubmed/26465987">PubMed Abstract </a> | <a target=xrefwindow id=d10215e992 href="http://dx.doi.org/10.1056/NEJMra1400972">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725877018">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731120594"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1005 class=n-a></a>Nordlund J, Syvänen A: Epigenetics in pediatric acute lymphoblastic leukemia. <i>Semin Cancer Biol.</i> 2017. <a target=xrefwindow id=d10215e1010 href="http://www.ncbi.nlm.nih.gov/pubmed/28887175">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1013 href="http://dx.doi.org/10.1016/j.semcancer.2017.09.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731120594">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725483919"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1027 class=n-a></a>Li B, Li H, Bai Y, <i> et al.</i>: Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL. <i>Nat Med.</i> 2015; <b>21</b>(6): 563–71. <a target=xrefwindow id=d10215e1038 href="http://www.ncbi.nlm.nih.gov/pubmed/25962120">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1041 href="http://dx.doi.org/10.1038/nm.3840">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1045 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4670083">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725483919">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725451796"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1058 class=n-a></a>Malinowska-Ozdowy K, Frech C, Schönegger A, <i> et al.</i>: <i>KRAS</i> and <i>CREBBP</i> mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia. <i>Leukemia.</i> 2015; <b>29</b>(8): 1656–67. <a target=xrefwindow id=d10215e1076 href="http://www.ncbi.nlm.nih.gov/pubmed/25917266">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1079 href="http://dx.doi.org/10.1038/leu.2015.107">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1082 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4530204">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725451796">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d10215e1095 class=n-a></a>Mar BG, Bullinger LB, McLean KM, <i> et al.</i>: Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. <i>Nat Commun.</i> 2014; <b>5</b>: 3469. <a target=xrefwindow id=d10215e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/24662245">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1109 href="http://dx.doi.org/10.1038/ncomms4469">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1113 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4016990">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d10215e1122 class=n-a></a>Yang JJ, Bhojwani D, Yang W, <i> et al.</i>: Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. <i>Blood.</i> 2008; <b>112</b>(10): 4178–83. <a target=xrefwindow id=d10215e1133 href="http://www.ncbi.nlm.nih.gov/pubmed/18768390">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1136 href="http://dx.doi.org/10.1182/blood-2008-06-165027">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1140 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2581992">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727114940"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1149 class=n-a></a>Tasian SK, Hunger SP: Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics. <i>Br J Haematol.</i> 2017; <b>176</b>(6): 867–82. <a target=xrefwindow id=d10215e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/27984637">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1160 href="http://dx.doi.org/10.1111/bjh.14474">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1163 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5352516">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727114940">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d10215e1176 class=n-a></a>Greaves M: Darwin and evolutionary tales in leukemia. The Ham-Wasserman Lecture. <i>Hematology Am Soc Hematol Educ Program.</i> 2009; <b>2009</b>: 3–12. <a target=xrefwindow id=d10215e1184 href="http://www.ncbi.nlm.nih.gov/pubmed/20008176">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1187 href="http://dx.doi.org/10.1182/asheducation-2009.1.3">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725372087"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1197 class=n-a></a>Andersson AK, Ma J, Wang J, <i> et al.</i>: The landscape of somatic mutations in infant <i>MLL</i>-rearranged acute lymphoblastic leukemias. <i>Nat Genet.</i> 2015; <b>47</b>(4): 330–7. <a target=xrefwindow id=d10215e1211 href="http://www.ncbi.nlm.nih.gov/pubmed/25730765">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1215 href="http://dx.doi.org/10.1038/ng.3230">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1218 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4553269">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725372087">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d10215e1231 class=n-a></a>Bernt KM, Armstrong SA: Targeting epigenetic programs in <i>MLL</i>-rearranged leukemias. <i>Hematology Am Soc Hematol Educ Program.</i> 2011; <b>2011</b>: 354–60. <a target=xrefwindow id=d10215e1242 href="http://www.ncbi.nlm.nih.gov/pubmed/22160057">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1245 href="http://dx.doi.org/10.1182/asheducation-2011.1.354">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d10215e1254 class=n-a></a>Brown P, Levis M, Shurtleff S, <i> et al.</i>: FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression. <i>Blood.</i> 2005; <b>105</b>(2): 812–20. <a target=xrefwindow id=d10215e1265 href="http://www.ncbi.nlm.nih.gov/pubmed/15374878">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1268 href="http://dx.doi.org/10.1182/blood-2004-06-2498">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d10215e1277 class=n-a></a>Abstracts From the 48<sup>th</sup> Congress of the International Society of Paediatric Oncology (SIOP) Dublin, Ireland October 19-22, 2016. <i>Pediatr Blood Cancer.</i> 2016; <b>63 Suppl 3</b>: S5–S321. <a target=xrefwindow id=d10215e1288 href="http://www.ncbi.nlm.nih.gov/pubmed/27673274">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1291 href="http://dx.doi.org/10.1002/pbc.26233">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1146974"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1300 class=n-a></a>Mullighan CG, Su X, Zhang J, <i> et al.</i>: Deletion of <i>IKZF1</i> and prognosis in acute lymphoblastic leukemia. <i>N Engl J Med.</i> 2009; <b>360</b>: 470–80. <a target=xrefwindow id=d10215e1314 href="http://www.ncbi.nlm.nih.gov/pubmed/19129520">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1318 href="http://dx.doi.org/10.1056/NEJMoa0808253">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1321 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2674612">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1146974">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717954876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1334 class=n-a></a>Biondi A, Schrappe M, de Lorenzo P, <i> et al.</i>: Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. <i>Lancet Oncol.</i> 2012; <b>13</b>(9): 936–45. <a target=xrefwindow id=d10215e1345 href="http://www.ncbi.nlm.nih.gov/pubmed/22898679">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1348 href="http://dx.doi.org/10.1016/S1470-2045(12)70377-7">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1352 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3431502">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717954876">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165488"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1366 class=n-a></a>Schultz KR, Bowman WP, Aledo A, <i> et al.</i>: Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. <i>J Clin Oncol.</i> 2009; <b>27</b>(31): 5175–81. <a target=xrefwindow id=d10215e1377 href="http://www.ncbi.nlm.nih.gov/pubmed/19805687">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1380 href="http://dx.doi.org/10.1200/JCO.2008.21.2514">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2773475">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165488">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718243456"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1397 class=n-a></a>Schultz KR, Carroll A, Heerema NA, <i> et al.</i>: Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. <i>Leukemia.</i> 2014; <b>28</b>(7): 1467–71. <a target=xrefwindow id=d10215e1408 href="http://www.ncbi.nlm.nih.gov/pubmed/24441288">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1411 href="http://dx.doi.org/10.1038/leu.2014.30">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1415 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4282929">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718243456">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d10215e1428 class=n-a></a>Cazzaniga V, De Lorenzo P, Mottadelli F, <i> et al.</i>: Clonal Evolution and Lack of BCR-ABL1 Mutations in Pediatric Ph+ ALL Patients Resistant/Refractory to Imatinib Treatment. <i>Blood.</i> 2015; <b>126</b>(23): 2622. <a target=xrefwindow id=d10215e1439 href="http://www.bloodjournal.org/content/126/23/2622">Reference Source</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d10215e1448 class=n-a></a>Chang BH, Willis SG, Stork L, <i> et al.</i>: Imatinib resistant <i>BCR-ABL1</i> mutations at relapse in children with Ph<sup>+</sup> ALL: a Children's Oncology Group (COG) study. <i>Br J Haematol.</i> 2012; <b>157</b>(4): 507–10. <a target=xrefwindow id=d10215e1466 href="http://www.ncbi.nlm.nih.gov/pubmed/22299775">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1469 href="http://dx.doi.org/10.1111/j.1365-2141.2012.09039.x">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1472 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4290865">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d10215e1481 class=n-a></a>Den Boer ML, van Slegtenhorst M, de Menezes RX, <i> et al.</i>: A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. <i>Lancet Oncol.</i> 2009; <b>10</b>(2): 125–34. <a target=xrefwindow id=d10215e1492 href="http://www.ncbi.nlm.nih.gov/pubmed/19138562">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1495 href="http://dx.doi.org/10.1016/S1470-2045(08)70339-5">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1499 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2707020">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718775441"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1508 class=n-a></a>Roberts KG, Li Y, Payne-Turner D, <i> et al.</i>: Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. <i>N Engl J Med.</i> 2014; <b>371</b>(11): 1005–15. <a target=xrefwindow id=d10215e1519 href="http://www.ncbi.nlm.nih.gov/pubmed/25207766">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1522 href="http://dx.doi.org/10.1056/NEJMoa1403088">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1526 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4191900">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718775441">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d10215e1540 class=n-a></a>Harvey RC, Mullighan CG, Wang X, <i> et al.</i>: Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. <i>Blood.</i> 2010; <b>116</b>(23): 4874–84. <a target=xrefwindow id=d10215e1551 href="http://www.ncbi.nlm.nih.gov/pubmed/20699438">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1554 href="http://dx.doi.org/10.1182/blood-2009-08-239681">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1558 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3321747">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732876505"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1567 class=n-a></a>Furness CL, Mansur MB, Weston VJ, <i> et al.</i>: The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia. <i>Leukemia.</i> 2018. <a target=xrefwindow id=d10215e1575 href="http://www.ncbi.nlm.nih.gov/pubmed/29556024">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1578 href="http://dx.doi.org/10.1038/s41375-018-0046-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732876505">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d10215e1591 class=n-a></a>Bocker MT, Hellwig I, Breiling A, <i> et al.</i>: Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. <i>Blood.</i> 2011; <b>117</b>(19): e182–9. <a target=xrefwindow id=d10215e1602 href="http://www.ncbi.nlm.nih.gov/pubmed/21427290">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1605 href="http://dx.doi.org/10.1182/blood-2011-01-331926">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165481"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1614 class=n-a></a>Bröske AM, Vockentanz L, Kharazi S, <i> et al.</i>: DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. <i>Nat Genet.</i> 2009; <b>41</b>(11): 1207–15. <a target=xrefwindow id=d10215e1625 href="http://www.ncbi.nlm.nih.gov/pubmed/19801979">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1628 href="http://dx.doi.org/10.1038/ng.463">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165481">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d10215e1641 class=n-a></a>Burke MJ, Bhatla T: Epigenetic modifications in pediatric acute lymphoblastic leukemia. <i>Front Pediatr.</i> 2014; <b>2</b>: 42. <a target=xrefwindow id=d10215e1649 href="http://www.ncbi.nlm.nih.gov/pubmed/24860797">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1652 href="http://dx.doi.org/10.3389/fped.2014.00042">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4030177">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d10215e1664 class=n-a></a>McKeon C, Ohkubo H, Pastan I, <i> et al.</i>: Unusual methylation pattern of the alpha 2 (l) collagen gene. <i>Cell.</i> 1982; <b>29</b>(1): 203–10. <a target=xrefwindow id=d10215e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/7105182">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1678 href="http://dx.doi.org/10.1016/0092-8674(82)90104-0">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726932551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1688 class=n-a></a>Hale V, Hale GA, Brown PA, <i> et al.</i>: A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia. <i>Oncology.</i> 2017; <b>92</b>(2): 61–7. <a target=xrefwindow id=d10215e1699 href="http://www.ncbi.nlm.nih.gov/pubmed/27802447">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1702 href="http://dx.doi.org/10.1159/000452091">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726932551">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d10215e1715 class=n-a></a>Wong IH, Ng MH, Huang DP, <i> et al.</i>: Aberrant <i>p15</i> promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. <i>Blood.</i> 2000; <b>95</b>(6): 1942–9. <a target=xrefwindow id=d10215e1729 href="http://www.ncbi.nlm.nih.gov/pubmed/10706859">PubMed Abstract </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d10215e1738 class=n-a></a>Shteper PJ, Siegfried Z, Asimakopoulos FA, <i> et al.</i>: <i>ABL1</i> methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL. <i>Leukemia.</i> 2001; <b>15</b>(4): 575–82. <a target=xrefwindow id=d10215e1752 href="http://www.ncbi.nlm.nih.gov/pubmed/11368359">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1756 href="http://dx.doi.org/10.1038/sj.leu.2402026">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1018113"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1765 class=n-a></a>Zheng S, Ma X, Zhang L, <i> et al.</i>: Hypermethylation of the 5' CpG island of the <i>FHIT</i> gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. <i>Cancer Res.</i> 2004; <b>64</b>(6): 2000–6. <a target=xrefwindow id=d10215e1779 href="http://www.ncbi.nlm.nih.gov/pubmed/15026336">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1783 href="http://dx.doi.org/10.1158/0008-5472.CAN-03-2387">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1018113">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d10215e1796 class=n-a></a>Matsushita C, Yang Y, Takeuchi S, <i> et al.</i>: Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. <i>Oncol Rep.</i> 2004; <b>12</b>(1): 97–9. <a target=xrefwindow id=d10215e1807 href="http://www.ncbi.nlm.nih.gov/pubmed/15201966">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1810 href="http://dx.doi.org/10.3892/or.12.1.97">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d10215e1819 class=n-a></a>Dunwell TL, Hesson LB, Pavlova T, <i> et al.</i>: Epigenetic analysis of childhood acute lymphoblastic leukemia. <i>Epigenetics.</i> 2009; <b>4</b>(3): 185–93. <a target=xrefwindow id=d10215e1830 href="http://www.ncbi.nlm.nih.gov/pubmed/19430199">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1833 href="http://dx.doi.org/10.4161/epi.4.3.8752">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d10215e1843 class=n-a></a>Nordlund J, Bäcklin CL, Wahlberg P, <i> et al.</i>: Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. <i>Genome Biol.</i> 2013; <b>14</b>(9): r105. <a target=xrefwindow id=d10215e1854 href="http://www.ncbi.nlm.nih.gov/pubmed/24063430">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1857 href="http://dx.doi.org/10.1186/gb-2013-14-9-r105">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1861 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4014804">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d10215e1870 class=n-a></a>Nordlund J, Milani L, Lundmark A, <i> et al.</i>: DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission. <i>PLoS One.</i> 2012; <b>7</b>(4): e34513. <a target=xrefwindow id=d10215e1881 href="http://www.ncbi.nlm.nih.gov/pubmed/22493696">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1884 href="http://dx.doi.org/10.1371/journal.pone.0034513">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1888 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3321015">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726675215"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1897 class=n-a></a>Wahlberg P, Lundmark A, Nordlund J, <i> et al.</i>: DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic <i>de novo</i> DNA methylation in CpG islands. <i>Epigenomics.</i> 2016; <b>8</b>(10): 1367–87. <a target=xrefwindow id=d10215e1911 href="http://www.ncbi.nlm.nih.gov/pubmed/27552300">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1915 href="http://dx.doi.org/10.2217/epi-2016-0052">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726675215">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718430957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1928 class=n-a></a>Figueroa ME, Chen SC, Andersson AK, <i> et al.</i>: Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. <i>J Clin Invest.</i> 2013; <b>123</b>(7): 3099–111. <a target=xrefwindow id=d10215e1939 href="http://www.ncbi.nlm.nih.gov/pubmed/23921123">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1942 href="http://dx.doi.org/10.1172/JCI66203">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1946 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3696550">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718430957">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727418496"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1959 class=n-a></a>Iacobucci I, Mullighan CG: Genetic Basis of Acute Lymphoblastic Leukemia. <i>J Clin Oncol.</i> 2017; <b>35</b>(9): 975–83. <a target=xrefwindow id=d10215e1967 href="http://www.ncbi.nlm.nih.gov/pubmed/28297628">PubMed Abstract </a> | <a target=xrefwindow id=d10215e1970 href="http://dx.doi.org/10.1200/JCO.2016.70.7836">Publisher Full Text </a> | <a target=xrefwindow id=d10215e1973 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455679">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727418496">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727413669"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e1986 class=n-a></a>Abdullah M, Choo CW, Alias H, <i> et al.</i>: <i>ADAMTSL5</i> and <i>CDH11</i>: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia. <i>Hematology.</i> 2017; <b>22</b>(7): 386–91. <a target=xrefwindow id=d10215e2004 href="http://www.ncbi.nlm.nih.gov/pubmed/28292214">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2007 href="http://dx.doi.org/10.1080/10245332.2017.1299417">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727413669">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d10215e2021 class=n-a></a>Milani L, Lundmark A, Kiialainen A, <i> et al.</i>: DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. <i>Blood.</i> 2010; <b>115</b>(6): 1214–25. <a target=xrefwindow id=d10215e2032 href="http://www.ncbi.nlm.nih.gov/pubmed/19965625">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2035 href="http://dx.doi.org/10.1182/blood-2009-04-214668">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d10215e2044 class=n-a></a>Sandoval J, Heyn H, Méndez-González J, <i> et al.</i>: Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia. <i>Br J Haematol.</i> 2013; <b>160</b>(3): 406–9. <a target=xrefwindow id=d10215e2055 href="http://www.ncbi.nlm.nih.gov/pubmed/23110451">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2058 href="http://dx.doi.org/10.1111/bjh.12113">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2062 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3568176">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d10215e2071 class=n-a></a>Hogan LE, Meyer JA, Yang J, <i> et al.</i>: Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. <i>Blood.</i> 2011; <b>118</b>(19): 5218–26. <a target=xrefwindow id=d10215e2082 href="http://www.ncbi.nlm.nih.gov/pubmed/21921043">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2085 href="http://dx.doi.org/10.1182/blood-2011-04-345595">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2089 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3217405">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725731941"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2098 class=n-a></a>Kunz JB, Rausch T, Bandapalli OR, <i> et al.</i>: Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation. <i>Haematologica.</i> 2015; <b>100</b>(11): 1442–50. <a target=xrefwindow id=d10215e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/26294725">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2112 href="http://dx.doi.org/10.3324/haematol.2015.129692">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2116 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4825305">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725731941">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d10215e2129 class=n-a></a>Bujko M, Musialik E, Olbromski R, <i> et al.</i>: Repetitive genomic elements and overall DNA methylation changes in acute myeloid and childhood B-cell lymphoblastic leukemia patients. <i>Int J Hematol.</i> 2014; <b>100</b>(1): 79–87. <a target=xrefwindow id=d10215e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/24841671">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2143 href="http://dx.doi.org/10.1007/s12185-014-1592-0">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d10215e2152 class=n-a></a>Bhatla T, Wang J, Morrison DJ, <i> et al.</i>: Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. <i>Blood.</i> 2012; <b>119</b>(22): 5201–10. <a target=xrefwindow id=d10215e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/22496163">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2166 href="http://dx.doi.org/10.1182/blood-2012-01-401687">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3369610">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1001607"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2180 class=n-a></a>Rea S, Eisenhaber F, O'Carroll D, <i> et al.</i>: Regulation of chromatin structure by site-specific histone H3 methyltransferases. <i>Nature.</i> 2000; <b>406</b>(6796): 593–9. <a target=xrefwindow id=d10215e2191 href="http://www.ncbi.nlm.nih.gov/pubmed/10949293">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2194 href="http://dx.doi.org/10.1038/35020506">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1001607">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d10215e2207 class=n-a></a>Krivtsov AV, Feng Z, Lemieux ME, <i> et al.</i>: H3K79 methylation profiles define murine and human MLL-AF4 leukemias. <i>Cancer Cell.</i> 2008; <b>14</b>(5): 355–68. <a target=xrefwindow id=d10215e2218 href="http://www.ncbi.nlm.nih.gov/pubmed/18977325">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2221 href="http://dx.doi.org/10.1016/j.ccr.2008.10.001">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2225 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2591932">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725418802"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2234 class=n-a></a>Nordlund J, Bäcklin CL, Zachariadis V, <i> et al.</i>: DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia. <i>Clin Epigenetics.</i> 2015; <b>7</b>(1): 11. <a target=xrefwindow id=d10215e2245 href="http://www.ncbi.nlm.nih.gov/pubmed/25729447">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2248 href="http://dx.doi.org/10.1186/s13148-014-0039-z">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2252 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4343276">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725418802">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726482733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2265 class=n-a></a>Hohmann AF, Martin LJ, Minder JL, <i> et al.</i>: Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. <i>Nat Chem Biol.</i> 2016; <b>12</b>(9): 672–9. <a target=xrefwindow id=d10215e2276 href="http://www.ncbi.nlm.nih.gov/pubmed/27376689">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2279 href="http://dx.doi.org/10.1038/nchembio.2115">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2283 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4990482">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726482733">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4671983"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2296 class=n-a></a>Reynoird N, Schwartz BE, Delvecchio M, <i> et al.</i>: Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. <i>EMBO J.</i> 2010; <b>29</b>(17): 2943–52. <a target=xrefwindow id=d10215e2307 href="http://www.ncbi.nlm.nih.gov/pubmed/20676058">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2310 href="http://dx.doi.org/10.1038/emboj.2010.176">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2944051">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4671983">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726403488"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2327 class=n-a></a>Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, <i> et al.</i>: Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. <i>Nat Commun.</i> 2016; <b>7</b>: 11790. <a target=xrefwindow id=d10215e2338 href="http://www.ncbi.nlm.nih.gov/pubmed/27265895">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2341 href="http://dx.doi.org/10.1038/ncomms11790">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4897744">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726403488">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727053258"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2359 class=n-a></a>Qian M, Zhang H, Kham SK, <i> et al.</i>: Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. <i>Genome Res.</i> 2017; <b>27</b>(2): 185–95. <a target=xrefwindow id=d10215e2370 href="http://www.ncbi.nlm.nih.gov/pubmed/27903646">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2373 href="http://dx.doi.org/10.1101/gr.209163.116">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2377 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5287225">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727053258">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d10215e2390 class=n-a></a>A Phase 1, Open-Label, Dose-Escalation &amp; Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability, PK &amp; PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving Translocation of the MLL Gene at 11q23 or Advanced Hematologic Malignancies. <a target=xrefwindow id=d10215e2392 href="https://clinicaltrials.gov/ct2/show/results/NCT01684150">Reference Source</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d10215e2401 class=n-a></a>Li KK, Huang K, Kondengaden S, <i> et al.</i>: Histone Methyltransferase Inhibitors for CancerTherapy. In <i>Epigenetic Technological Applications.</i> Chapter 17, 2015; 363–395. <a target=xrefwindow id=d10215e2409 href="http://dx.doi.org/10.1016/B978-0-12-801080-8.00017-X">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716197950"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2418 class=n-a></a>Zhang J, Ding L, Holmfeldt L, <i> et al.</i>: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. <i>Nature.</i> 2012; <b>481</b>(7380): 157–63. <a target=xrefwindow id=d10215e2429 href="http://www.ncbi.nlm.nih.gov/pubmed/22237106">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2432 href="http://dx.doi.org/10.1038/nature10725">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2436 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3267575">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716197950">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726744990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2449 class=n-a></a>Hirabayashi S, Ohki K, Nakabayashi K, <i> et al.</i>: ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. <i>Haematologica.</i> 2017; <b>102</b>(1): 118–29. <a target=xrefwindow id=d10215e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/27634205">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2463 href="http://dx.doi.org/10.3324/haematol.2016.151035">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2467 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5210242">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726744990">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d10215e2480 class=n-a></a>Ju X, Li D, Shi Q, <i> et al.</i>: Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. <i>Pediatr Hematol Oncol.</i> 2009; <b>26</b>(1): 1–10. <a target=xrefwindow id=d10215e2491 href="http://www.ncbi.nlm.nih.gov/pubmed/19206004">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2494 href="http://dx.doi.org/10.1080/08880010802378338">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d10215e2504 class=n-a></a>Mi S, Lu J, Sun M, <i> et al.</i>: MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. <i>Proc Natl Acad Sci U S A.</i> 2007; <b>104</b>(50): 19971–6. <a target=xrefwindow id=d10215e2515 href="http://www.ncbi.nlm.nih.gov/pubmed/18056805">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2518 href="http://dx.doi.org/10.1073/pnas.0709313104">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2522 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2148407">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d10215e2531 class=n-a></a>Schotte D, Chau JC, Sylvester G, <i> et al.</i>: Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. <i>Leukemia.</i> 2009; <b>23</b>(2): 313–22. <a target=xrefwindow id=d10215e2542 href="http://www.ncbi.nlm.nih.gov/pubmed/18923441">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2545 href="http://dx.doi.org/10.1038/leu.2008.286">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d10215e2554 class=n-a></a>Zanette DL, Rivadavia F, Molfetta GA, <i> et al.</i>: miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. <i>Braz J Med Biol Res.</i> 2007; <b>40</b>(11): 1435–40. <a target=xrefwindow id=d10215e2565 href="http://www.ncbi.nlm.nih.gov/pubmed/17934639">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2568 href="http://dx.doi.org/10.1590/S0100-879X2006005000179">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d10215e2577 class=n-a></a>Ajit SK: Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. <i>Sensors (Basel).</i> 2012; <b>12</b>(3): 3359–69. <a target=xrefwindow id=d10215e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/22737013">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2588 href="http://dx.doi.org/10.3390/s120303359">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2591 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3376561">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d10215e2600 class=n-a></a>de Oliveira JC, Brassesco MS, Scrideli CA, <i> et al.</i>: MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL). <i>Pediatr Blood Cancer.</i> 2012; <b>59</b>(4): 599–604. <a target=xrefwindow id=d10215e2611 href="http://www.ncbi.nlm.nih.gov/pubmed/22492670">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2614 href="http://dx.doi.org/10.1002/pbc.24167">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d10215e2623 class=n-a></a>de Oliveira JC, Scrideli CA, Brassesco MS, <i> et al.</i>: Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. <i>Leuk Res.</i> 2012; <b>36</b>(3): 293–8. <a target=xrefwindow id=d10215e2634 href="http://www.ncbi.nlm.nih.gov/pubmed/22099053">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2637 href="http://dx.doi.org/10.1016/j.leukres.2011.10.005">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d10215e2647 class=n-a></a>Zhang H, Luo X, Zhang P, <i> et al.</i>: MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. <i>PLoS One.</i> 2009; <b>4</b>(11): e7826. <a target=xrefwindow id=d10215e2658 href="http://www.ncbi.nlm.nih.gov/pubmed/19915715">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2661 href="http://dx.doi.org/10.1371/journal.pone.0007826">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2773830">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d10215e2674 class=n-a></a>Schotte D, De Menezes RX, Akbari Moqadam F, <i> et al.</i>: MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. <i>Haematologica.</i> 2011; <b>96</b>(5): 703–11. <a target=xrefwindow id=d10215e2685 href="http://www.ncbi.nlm.nih.gov/pubmed/21242186">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2688 href="http://dx.doi.org/10.3324/haematol.2010.026138">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2692 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3084917">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d10215e2701 class=n-a></a>Rodić N, Zampella JG, Cornish TC, <i> et al.</i>: Translocation junctions in <i>TCF3-PBX1</i> acute lymphoblastic leukemia/lymphoma cluster near transposable elements. <i>Mob DNA.</i> 2013; <b>4</b>(1): 22. <a target=xrefwindow id=d10215e2715 href="http://www.ncbi.nlm.nih.gov/pubmed/24135088">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2719 href="http://dx.doi.org/10.1186/1759-8753-4-22">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4015642">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d10215e2731 class=n-a></a>Ramos KS, Bojang P: 8.30 - Long Interspersed Nuclear Element (LINE-1/L1). <i>Comprehensive Toxicology.</i> Elsevier; 2017; <b>8</b>: 626–643. <a target=xrefwindow id=d10215e2739 href="http://dx.doi.org/10.1016/b978-0-12-801238-3.01922-x">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d10215e2748 class=n-a></a>Montoya-Durango DE, Ramos KS: L1 retrotransposon and retinoblastoma: molecular linkages between epigenetics and cancer. <i>Curr Mol Med.</i> 2010; <b>10</b>(5): 511–21. <a target=xrefwindow id=d10215e2756 href="http://www.ncbi.nlm.nih.gov/pubmed/20540701">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2759 href="http://dx.doi.org/10.2174/156652410791608234">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d10215e2768 class=n-a></a>Bojang P Jr, Ramos KS: The promise and failures of epigenetic therapies for cancer treatment. <i>Cancer Treat Rev.</i> 2014; <b>40</b>(1): 153–69. <a target=xrefwindow id=d10215e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/23831234">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2779 href="http://dx.doi.org/10.1016/j.ctrv.2013.05.009">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2782 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3823804">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d10215e2792 class=n-a></a>Montoya-Durango DE, Ramos KA, Bojang P, <i> et al.</i>: LINE-1 silencing by retinoblastoma proteins is effected through the nucleosomal and remodeling deacetylase multiprotein complex. <i>BMC Cancer.</i> 2016; <b>16</b>: 38. <a target=xrefwindow id=d10215e2803 href="http://www.ncbi.nlm.nih.gov/pubmed/26810492">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2806 href="http://dx.doi.org/10.1186/s12885-016-2068-9">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2810 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4727354">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d10215e2819 class=n-a></a>Teneng I, Montoya-Durango DE, Quertermous JL, <i> et al.</i>: Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. <i>Epigenetics.</i> 2011; <b>6</b>(3): 355–67. <a target=xrefwindow id=d10215e2830 href="http://www.ncbi.nlm.nih.gov/pubmed/21150308">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2833 href="http://dx.doi.org/10.4161/epi.6.3.14282">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3092684">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d10215e2846 class=n-a></a>Markaki EA, Tsopanomichalou M, Dimitriou H, <i> et al.</i>: Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma. <i>Pediatr Hematol Oncol.</i> 2001; <b>18</b>(2): 101–10. <a target=xrefwindow id=d10215e2857 href="http://www.ncbi.nlm.nih.gov/pubmed/11255727">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2860 href="http://dx.doi.org/10.1080/088800101300002928">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d10215e2869 class=n-a></a>Siegel D, Martin T, Nooka A, <i> et al.</i>: Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies. <i>Haematologica.</i> 2013; <b>98</b>(11): 1753–61. <a target=xrefwindow id=d10215e2880 href="http://www.ncbi.nlm.nih.gov/pubmed/23935022">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2883 href="http://dx.doi.org/10.3324/haematol.2013.089334">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3815177">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727367645"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2896 class=n-a></a>Studd JB, Vijayakrishnan J, Yang M, <i> et al.</i>: Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2. <i>Nat Commun.</i> 2017; <b>8</b>: 14616. <a target=xrefwindow id=d10215e2907 href="http://www.ncbi.nlm.nih.gov/pubmed/28256501">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2910 href="http://dx.doi.org/10.1038/ncomms14616">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5337971">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727367645">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1119574"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2927 class=n-a></a>Figueroa ME, Reimers M, Thompson RF, <i> et al.</i>: An integrative genomic and epigenomic approach for the study of transcriptional regulation. <i>PLoS One.</i> 2008; <b>3</b>(3): e1882. <a target=xrefwindow id=d10215e2938 href="http://www.ncbi.nlm.nih.gov/pubmed/18365023">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2941 href="http://dx.doi.org/10.1371/journal.pone.0001882">Publisher Full Text </a> | <a target=xrefwindow id=d10215e2945 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2266992">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1119574">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725899019"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e2959 class=n-a></a>Janczar K, Janczar S, Pastorczak A, <i> et al.</i>: Preserved global histone H4 acetylation linked to <i>ETV6-RUNX1</i> fusion and <i>PAX5</i> deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia. <i>Leuk Res.</i> 2015; <b>39</b>(12): 1455–61. <a target=xrefwindow id=d10215e2977 href="http://www.ncbi.nlm.nih.gov/pubmed/26520622">PubMed Abstract </a> | <a target=xrefwindow id=d10215e2980 href="http://dx.doi.org/10.1016/j.leukres.2015.10.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725899019">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d10215e2993 class=n-a></a>Sonnemann J, Gruhn B, Wittig S, <i> et al.</i>: Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents. <i>Br J Haematol.</i> 2012; <b>158</b>(5): 664–6. <a target=xrefwindow id=d10215e3004 href="http://www.ncbi.nlm.nih.gov/pubmed/22686282">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3007 href="http://dx.doi.org/10.1111/j.1365-2141.2012.09187.x">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726144733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3016 class=n-a></a>Schwab C, Ryan SL, Chilton L, <i> et al.</i>: <i>EBF1-PDGFRB</i> fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications. <i>Blood.</i> 2016; <b>127</b>(18): 2214–8. <a target=xrefwindow id=d10215e3030 href="http://www.ncbi.nlm.nih.gov/pubmed/26872634">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3034 href="http://dx.doi.org/10.1182/blood-2015-09-670166">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726144733">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718174783"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3047 class=n-a></a>Buitenkamp TD, Izraeli S, Zimmermann M, <i> et al.</i>: Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. <i>Blood.</i> 2014; <b>123</b>(1): 70–7. <a target=xrefwindow id=d10215e3058 href="http://www.ncbi.nlm.nih.gov/pubmed/24222333">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3061 href="http://dx.doi.org/10.1182/blood-2013-06-509463">Publisher Full Text </a> | <a target=xrefwindow id=d10215e3065 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3879907">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718174783">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2678956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3078 class=n-a></a>Russell LJ, Capasso M, Vater I, <i> et al.</i>: Deregulated expression of cytokine receptor gene, <i>CRLF2</i>, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. <i>Blood.</i> 2009; <b>114</b>(13): 2688–98. <a target=xrefwindow id=d10215e3092 href="http://www.ncbi.nlm.nih.gov/pubmed/19641190">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3096 href="http://dx.doi.org/10.1182/blood-2009-03-208397">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2678956">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1123377"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3109 class=n-a></a>Bercovich D, Ganmore I, Scott LM, <i> et al.</i>: Mutations of <i>JAK2</i> in acute lymphoblastic leukaemias associated with Down's syndrome. <i>Lancet.</i> 2008; <b>372</b>(9648): 1484–92. <a target=xrefwindow id=d10215e3123 href="http://www.ncbi.nlm.nih.gov/pubmed/18805579">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3127 href="http://dx.doi.org/10.1016/S0140-6736(08)61341-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1123377">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717972292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3141 class=n-a></a>Holmfeldt L, Wei L, Diaz-Flores E, <i> et al.</i>: The genomic landscape of hypodiploid acute lymphoblastic leukemia. <i>Nat Genet.</i> 2013; <b>45</b>(3): 242–52. <a target=xrefwindow id=d10215e3152 href="http://www.ncbi.nlm.nih.gov/pubmed/23334668">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3155 href="http://dx.doi.org/10.1038/ng.2532">Publisher Full Text </a> | <a target=xrefwindow id=d10215e3159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3919793">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717972292">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725483956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10215e3172 class=n-a></a>Paulsson K, Lilljebjörn H, Biloglav A, <i> et al.</i>: The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. <i>Nat Genet.</i> 2015; <b>47</b>(6): 672–6. <a target=xrefwindow id=d10215e3183 href="http://www.ncbi.nlm.nih.gov/pubmed/25961940">PubMed Abstract </a> | <a target=xrefwindow id=d10215e3186 href="http://dx.doi.org/10.1038/ng.3301">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725483956">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1104/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1104/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona College of Medicine-Tucson, Tucson, USA<br/> <sup>2</sup> Department of Promotion Health Sciences, University of Arizona Mel and Enid Zucherman College of Public Health, Tucson, USA<br/> <sup>3</sup> Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Arizona College of Medicine-Tucson, Tucson, USA<br/> <sup>4</sup> University of Arizona Cancer Center, Tucson, USA<br/> <sup>5</sup> Department of Medicine, Division of Clinical Support and Data Analytics, University of Arizona College of Medicine-Phoenix, Phoenix, USA<br/> <p> <div class=margin-bottom> Kristie N Ramos <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Irma N Ramos <br/> <span>Roles: </span> Data Curation, Formal Analysis, Funding Acquisition, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Yi Zeng <br/> <span>Roles: </span> Formal Analysis, Funding Acquisition, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Kenneth S Ramos <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1104/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 18 Jul 2018, 7:1104 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14634.1">https://doi.org/10.12688/f1000research.14634.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Ramos KN <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15926 data-id=14634 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14634.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1104/v1/pdf?article_uuid=0fe6f3da-4f45-424f-8298-0785c40d9769" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14634.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Ramos KN, Ramos IN, Zeng Y and Ramos KS. Genetics and epigenetics of pediatric leukemia in the era of precision medicine [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1104 (<a href="https://doi.org/10.12688/f1000research.14634.1" target=_blank>https://doi.org/10.12688/f1000research.14634.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14634 id=mobile-track-article-signin-14634 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14634?target=/articles/7-1104/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15926 /> <input name=articleId type=hidden value=14634 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Sinisa Dovat</strong>, Department of Pediatrics, Pennsylvania State University College of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Brian Huntly</strong>, Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1104/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1104/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36469-35952></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36470-35953></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1104/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>18 Jul 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sinisa Dovat</strong>, Department of Pediatrics, Pennsylvania State University College of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Brian Huntly</strong>, Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1104/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1104/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Genetics and epigenetics of pediatric leukemia...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1104/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1104/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1104/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Ramos KN et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1104/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1104",
            templates : {
                twitter : "Genetics and epigenetics of pediatric leukemia in the era of.... Ramos KN et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1104/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Genetics and epigenetics of pediatric leukemia in the era of precision medicine", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Genetics and epigenetics of pediatric leukemia in the era of precision medicine", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14634/15926")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15926");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "35952": 0,
                           "35953": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "746b8f14-acb4-468e-b6b7-424b275a7482";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1104.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1104.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1104.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1104.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1104.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>